Study With Heparin Sodium in Subcutaneous Administration

NCT03113084 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

38

Enrollment

INDUSTRY

Sponsor class

Stopped Delay in the R\&D stage

Conditions

Heparin

Interventions

BIOLOGICAL: Sodium Heparin UQ subcutaneous drug administration
BIOLOGICAL: Sodium Heparin FK subcutaneous drug administration

Sponsor

União Química Farmacêutica Nacional S/A

Collaborators

[object Object]